These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 28163909)
41. Is NSAID use in children associated with the risk of renal injury? Kirpalani A; Rieder M Paediatr Child Health; 2019 May; 24(2):119-121. PubMed ID: 30996603 [TBL] [Abstract][Full Text] [Related]
45. Use of the NINJA (Nephrotoxic Injury Negated by Just-in-Time Action) Program to Identify Nephrotoxicity in Pediatric Patients with Cystic Fibrosis. Newton ES; Kurzen EA; Linnemann RW; Shin HS J Pediatr Pharmacol Ther; 2021; 26(4):379-383. PubMed ID: 34035683 [TBL] [Abstract][Full Text] [Related]
46. Implementation Strategies for Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action) to Prevent Neonatal Medication-Induced Kidney Injury. Stone SB; Bisaccia E; Zakhary MS; Bashqoy F; Wagner D; Stoops C J Pediatr Pharmacol Ther; 2023; 28(4):287-296. PubMed ID: 37795277 [TBL] [Abstract][Full Text] [Related]
47. Evidence-based development of a nephrotoxic medication list to screen for acute kidney injury risk in hospitalized children. Goswami E; Ogden RK; Bennett WE; Goldstein SL; Hackbarth R; Somers MJG; Yonekawa K; Misurac J Am J Health Syst Pharm; 2019 Oct; 76(22):1869-1874. PubMed ID: 31665764 [TBL] [Abstract][Full Text] [Related]
48. Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysis. Downes KJ; Dong M; Fukuda T; Clancy JP; Haffner C; Bennett MR; Vinks AA; Goldstein SL J Antimicrob Chemother; 2017 Jan; 72(1):254-260. PubMed ID: 27585963 [TBL] [Abstract][Full Text] [Related]